The following clinical trials and studies seek participants:
Volunteers Needed for Research Study Investigating Pain and Memory
Volunteers are needed for a study that investigates chronic pain and memory. The study involves completing simple computer tasks to test memory and attention.
The study requires participating in two sessions. The first one will take place before pain-relieving surgery, and the second will take place one to two months after surgery. Each session will take about one hour.
In order to participate, you must:
- Be 18 years or older
- Speak English as your first language
- Have experienced pain for at least the previous 6 months
- Be seeding pain-relieving susrgery
You will receive compensation for your participation. If you would like to receive further information about the study, please e-mail the research group: email@example.com
New Study in the School of Health Professions
UT Southwestern Medical Center
You are invited to participate in a study that is being conducted among patients diagnosed with Multiple Sclerosis (MS). The objective of this study is to evaluate the usefulness of questionnaires used to assess MS-related symptoms. We are looking for people who:
1. Have any form of MS
2. 18 years and older
3. Able to walk, even briefly, with or without assistive devices
Your participation will include psychosocial questionnaires, two cognitive tests, and a brief physical activity test. The evaluation will take approximately an hour and 45 minutes. You will be asked to come back in 6 to 8 weeks for a re-evaluation. Feedback regarding your two evaluations will be provided if you request.
If you are interested, please contact:
Amanda Riggs 972-658-7587
If you have any questions about the study, please contact Professor Chung-Yi Chiu at 469-422-1677 or by email
If you are living with Multiple Sclerosis . . . Are you in control of your bladder, or is your bladder in control of you?
If you're a person living with multiple Sclerosis and are suffering with urinary leakage, you may want to consider taking part in a medical research study.
You must meeting the following criteria:
- 18 years or older
- Stable multiple sclerosis for three months
- Have had urinary leakage for at least three months
- Have used at least one overactive bladder medication
- Not using clean-intermittent self-catheterization (CIC) or an indwelling catheter to manager your urinary leakage.
The DIGNITY2 study is assessing a new investagational dosage of an approved medication to control urinary incontenence (leakage) as a result of the bladder problems that can occur in people with multiple sclerosis.
If you would like to know more about the study please contact your local DIGNITY2 study team directly (Leah Renfro, Regional Urology, LLC at 316-683-0411 Ext. 125) or visit the DIGINITY2 website at www.DIGNITY2study.com
Research Study: Participants with Mobility Impairments Needed
Persons with mobility impairments ages 18+ who use assistive devices, such as canes, walkers, or wheelchairs, are sought for a research study on virtual reality video games and their potential role in rehabilitation. Individuals without impairments are also welcome to participate. In this study, participants will be asked to answer survey questions and play video games. The study will take approximately 1-1.5 hours. Participants will be compensated $50 for their time and effort.
This study is conducted by John Quarles, Ph.D., from the University of Texas at San Antonio (UTSA), Department of Computer Science. The study location is at UTSA. Email firstname.lastname@example.org or call 210-595-9415 for details. Please contact us today since the number of participants is limited.
Health Promotion for MS
You are invited to participate in a study that is being conducted among patients diagnosed with Multiple Sclerosis (MS). The objective of this research is to understand the perspectives of individuals with MS on issues related to health activities. We are looking for people who:
- Have a diagnosis of MS
- Hispanic/Latino or African American
- 18-65 years of age
- Speak English
- Live in the community
You will participate in a focus group with other people who have MS for approximately one and a half hours to ask questions about how you maintain your general health. You will also fill out a survey. After you finish the complete survey and attend a focus group, we will gratefully reward you a $40 gift card. The study has been approved by UT Southwestern Medical Center.
If you are interested please contact:
Oral Medication Study for Primary Progressive MS
The dawn of discovery in MS management begins with you. Consider participating in a clinical research study of an oral investigational medication for primary progressive MS (PPMS). This study will evaluate whether the investigational medication is safe and effective in slowing disease progression associated with PPMS.
Participants must be 25 to 65 years old with PPMS that has progressed for at least 1 year and have at least two of the following:
• Positive brain MRI
• Positive spinal MRI
• Positive CSF
If eligible, you will participate in the study for up to 5 years and attend 18 scheduled study visits.
All study medication and study doctor’s visits will be provided at no cost to you.
For more information, contact:
Kristen A. Ballesteros, Ph.D.
Clinical Research Counselor
Integra Clinical Research
3603 Paesanos Pky
San Antonio, TX 78231
210-853-3964 or 614-4884 option 2
Persons with MS ages 18-60 who are having problems with memory or other cognitive skills are sought to participate in a research project that encourages development of strategies to help you improve cognitive functioning in everyday life. Groups of 10-12 people diagnosed with MS who meet the study criteria will meet for eight two-hour sessions in Houston or Austin. Participants will be provided with access to a computer program to practice skills at home to improve memory, attention and problem solving, and asked to complete questionnaires and a series of cognitive tests three times throughout the duration of the five-month project. Each participant will receive $150 for completion of the study.
This study is conducted by Alexa Stuifbergen, Ph.D., R.N., and Heather Becker, Ph.D., of The University of Texas at Austin and Francisco Perez, Ph.D., of Houston. It is funded by the National Institutes of Health. For details, call Vicki at 512-471-9077 or 1-800-687-8010 or by e-mail at email@example.com today.
Individuals with MS ages 18-75 with balance problems are sought for a study on identifying balance deficits and improving these deficits through the use of a home exercise program. Groups of 8-10 people diagnosed with MS who meet the study criteria will meet at Texas Woman's University in Dallas for two hours of testing and training. Participants will be provided a CD demonstrating the exercise program and an exercise log to guide the exercise process. Selected participants will be asked to return after eight weeks of exercising for follow-up testing.
The study is conducted by Linda Csiza, PT, DSc, NCS at Texas Woman's University in Dallas. Contact Linda at 972-653-2235 or firstname.lastname@example.org.
Young Caregivers Study
Does your child (ages 15-18) live with a parent, grandparent or other adult family member who has a chronic medical condition or disability? For more information contact Christina Marbach at email@example.com or 210-382-3466.
Verbal Communication Study
Carolyn Baylor, a speech pathologist at the University of Washington in Seattle is seeking help from people with MS and other diseases that can affect speech and communication in developing a questionnaire for health care providers to use. The goal is for the questionnaire to be one of several tools that clinicians can use to help people with communication disorders improve their participation in activities they want to do. We have a large set of draft questions ready, and we need your help to create the final questionnaire. This study is for people who have experienced changes in their speech as a result of MS. We are also interested in cognitive changes, though the primary focus will be on changes in speech. The study involves about an hour of filling out questionnaires online or on paper, and can be done at home. Eligible participants would have MS with associated changes in speech, language or cognition. Participants must use speech as their primary communication method, although they may use writing or augmentative devices at times. Participants must live at home or in assisted living (not currently residing in a nursing facility). Participants who complete the study will receive $20 (choice of check or Amazon.com giftcard).
To participate, contact Carolyn Baylor at (206) 221-3563 or firstname.lastname@example.org. More information is available on the study website at: http://staff.washington.edu/cbaylor. If you leave a message, please include that you are interested in the “MS study.”
Women with MS Study
The University of Texas Southwestern (UTSW) is looking for women with relapsing-remitting MS for a 24 -month study to see if there are less relapses with the treatment of Copaxone injections plus oral estriol as compared to the treatment of Copaxone injections plus oral placebo. We are looking for:
• Women 18-50 years old
• Diagnosed with definite RRMS
• Able to walk without any aids such as cane or walker
• Had at least one relapse within the last 2 years
You are not eligible for the study if you are pregnant, breast-feeding, smoke, or have other serious medical conditions. Those treated in the past with Copaxone, Avonex, Rebif or Betaseron will NOT BE EXCLUDED.
This study is being conducted by Ardith Courtney, D.O.., Professor, UTSW, Department of Neurology. If you are interested, contact Gina Remington, the study coordinator at (214)645-0560. This trial is funded by the National Multiple Sclerosis Society and the National Institutes of Health. For more information, click here.
Cognitive / Optical Coherence Tomography (OCT) Study
Only patients with a diagnosis of relapsing, remitting Clinically Definitive Multiple Sclerosis (CDMS) or Clinically Isolated Syndrome will be included in the study. Time since diagnosis optimally within 2 or 3 years. For more information, click here.
Acute Optic Neuritis Treatment Trial (O.C.T.A.G.O.N. - TEVA Neuroscience)
Acute Optic Neuritis (AON) affects about 3 patients per 100,000 in the United States. Currently there are no options for their treatment other than steroid administration. Dr. Rosa Tang, MD is a principal investigator for a research study evaluating the clinical effectiveness and safety of Copaxone®, once daily injection, for patients with a first episode of AON.
The OCTAGON study is a multi-center, randomized double-blind, placebo-controlled trial that is being conducted within the United States. We are currently enrolling participants in this study and these patients will receive standard of care therapy, plus Copaxone once daily or placebo. All trial related costs will be covered by the Sponsor, Teva Neuroscience. Patients will receive a free eye exam. For more information, click here.